The live share price of ARS Pharmaceuticals trades actively on the Nasdaq exchange under the ticker symbol SPRY, hovering around five dollars and seventy-two cents per share. Equity valuations fluctuate continuously throughout active market trading hours based on commercial execution of its key allergy and anaphylaxis treatment products, institutional order volume, and biotechnology sector trends. Investors tracking exact second-by-second pricing should check live financial tracking terminals prior to executing portfolio transactions.